Theodore Schroeder
2019
In 2019, Theodore Schroeder earned a total compensation of $1.5M as Chief Executive Officer at Nabriva Therapeutics AG, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,250 |
|---|---|
| Option Awards | $478,367 |
| Salary | $560,000 |
| Stock Awards | $310,175 |
| Other | $28,372 |
| Total | $1,496,164 |
Schroeder received $560K in salary, accounting for 37% of the total pay in 2019.
Schroeder also received $119.3K in non-equity incentive plan, $478.4K in option awards, $310.2K in stock awards and $28.4K in other compensation.
Rankings
In 2019, Theodore Schroeder's compensation ranked 7,331st out of 13,971 executives tracked by ExecPay. In other words, Schroeder earned more than 47.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,331 out of 13,971 | 48th |
Division Manufacturing | 2,824 out of 5,695 | 50th |
Major group Chemicals And Allied Products | 1,054 out of 2,194 | 52nd |
Industry group Drugs | 897 out of 1,880 | 52nd |
Industry Pharmaceutical Preparations | 666 out of 1,392 | 52nd |
Source: SEC filing on June 25, 2020.
Schroeder's colleagues
We found two more compensation records of executives who worked with Theodore Schroeder at Nabriva Therapeutics AG in 2019.